首页 | 本学科首页   官方微博 | 高级检索  
   检索      

肿瘤靶向性载体的研究与利用:自主性细小病毒趋瘤性的开发
引用本文:罗祖玉,林万敏.肿瘤靶向性载体的研究与利用:自主性细小病毒趋瘤性的开发[J].生命科学,1999,11(2):72-74.
作者姓名:罗祖玉  林万敏
作者单位:复旦大学生命科学院!上海,200433,复旦大学生命科学院!上海,200433,复旦大学生命科学院!上海,200433,复旦大学生命科学院!上海,200433
摘    要:自主性细小病毒是一类单链DNA病毒,基因组大小约5kb,进入宿主细胞后其基因不整合到细胞染色体中,其中MVM和H—1还具有趋瘤性和抗瘤性。因此;可利用它们作为外源基因的载体,构建成趋向肿瘤细胞的重组病毒。在肿瘤的基因治疗中,重组自主性细小病毒有其独特的优点。

关 键 词:重组自主性细小病毒  载体  肿瘤基因治疗

Study and utilization of the cancer-targeting vectors -developing of the oncotropism and oncosuppression of auyonomous parvoviruses
LUO Zu-Yu,LIN Wan-Min, GUO Lan-Ping, HUANG Qing-Shan.Study and utilization of the cancer-targeting vectors -developing of the oncotropism and oncosuppression of auyonomous parvoviruses[J].Chinese Bulletin of Life Sciences,1999,11(2):72-74.
Authors:LUO Zu-Yu  LIN Wan-Min  GUO Lan-Ping  HUANG Qing-Shan
Abstract:Autonomous parvoviruses have single-stranded DNA with the genome of about5kb size. They are characterized by their oncotropism and oncosuppression. Their genes arenot integrated into the genomes of the chromosomes of the host cells. Autonomous parvoviruses,therefore, could be used as the vectors carrying foreign genes to construct recombinant autonomousparvoviruses. They have specific advantages in cancer gene therapy.
Keywords:recombinant autonomous parvovirus  vector  cancer gene therapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号